RXSTNasdaq United States
Market cap
$260.374 M
$6.26 +2.96%
Close of 7 Aug 2026
Revenue
$134.5M
#2429 by revenue
Earnings
-$38.90
Loss-making
Shares outstanding
41,593,256
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for RxSight are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.